<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001189</url>
  </required_header>
  <id_info>
    <org_study_id>830227</org_study_id>
    <secondary_id>83-C-0227</secondary_id>
    <nct_id>NCT00001189</nct_id>
  </id_info>
  <brief_title>The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors</brief_title>
  <official_title>The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Patients with Grade I soft tissue sarcomas or benign, non-metastasizing invasive soft tissue&#xD;
      tumors will receive wide local excision and be prospectively randomized as to either receive&#xD;
      or not receive radiation therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized study. Patients undergo surgical excision of all gross disease and then&#xD;
      are randomized to Arm I or Arm II.&#xD;
&#xD;
      Arm I: Radiotherapy. Involved-field irradiation.&#xD;
&#xD;
      Arm II: No further treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 1983</start_date>
  <completion_date>April 2001</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>150</enrollment>
  <condition>Sarcoma</condition>
  <condition>Neoplasms</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>radiotherapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
        Biopsy-proven grade I soft tissue sarcoma or one of the following benign but highly&#xD;
        invasive soft tissue tumors:&#xD;
&#xD;
        Abdominal and extra-abdominal fibromatosis (desmoid,&#xD;
&#xD;
        aggressive fibromatosis),&#xD;
&#xD;
        Dermatofibrosarcoma protuberans,&#xD;
&#xD;
        Intramuscular lipoma (infiltrating lipoma),&#xD;
&#xD;
        Diffuse lipomatosis,&#xD;
&#xD;
        Leiomyoma of deep soft tissue,&#xD;
&#xD;
        Diffuse giant cell tumor of tendon sheath (proliferative synovitis).&#xD;
&#xD;
        No clinical evidence of metastases in regional nodes or more distant sites.&#xD;
&#xD;
        No primary intraperitoneal or retroperitoneal tumors.&#xD;
&#xD;
        Resection of all gross tumor at the time of surgical excision required (margins may be&#xD;
        pathologically positive or negative).&#xD;
&#xD;
        No von Recklinghausen's disease.&#xD;
&#xD;
        PRIOR/CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic Therapy: Not specified.&#xD;
&#xD;
        Chemotherapy: No prior chemotherapy for sarcoma.&#xD;
&#xD;
        Endocrine Therapy: Not specified.&#xD;
&#xD;
        Radiotherapy: No prior radiotherapy for sarcoma.&#xD;
&#xD;
        Surgery: No more than 4 months since definitive surgery for&#xD;
&#xD;
        primary lesion or recurrence.&#xD;
&#xD;
        No prior amputation.&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age: 18 and over.&#xD;
&#xD;
        Performance status: Not specified.&#xD;
&#xD;
        Hematopoietic: Not specified.&#xD;
&#xD;
        Hepatic: No cirrhosis.&#xD;
&#xD;
        Renal: No evidence of severe renal impairment.&#xD;
&#xD;
        Cardiovascular: No ischemic heart disease.&#xD;
&#xD;
        OTHER:&#xD;
&#xD;
        No prior malignancy except basal cell carcinoma.&#xD;
&#xD;
        No serious infection.&#xD;
&#xD;
        No active bleeding disorder.&#xD;
&#xD;
        No severe concomitant disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Cancer Institute (NCI)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wara WM, Phillips TL, Hill DR, Bovill E Jr, Luk KH, Lichter AS, Leibel SA. Desmoid tumors--treatment and prognosis. Radiology. 1977 Jul;124(1):225-6. doi: 10.1148/124.1.225.</citation>
    <PMID>405711</PMID>
  </reference>
  <verification_date>May 2000</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>December 9, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2002</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Adjuvant Radiotherapy</keyword>
  <keyword>Low-Grade Sarcoma</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Randomized Study</keyword>
  <keyword>Sarcoma</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
    <mesh_term>Soft Tissue Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

